Russell Adams of The Wall Street Journal reports that drug manufacturer Mylan Pharmaceuticals has filed a defamation lawsuit against the Pittsburgh Post-Gazette, its second lawsuit against the paper this year.
“The U.S. Food and Drug Administration investigated the Mylan plant shortly after the article appeared and said it did not find any ‘objectionable’ deficiencies or evidence that the quality of Mylan products had been compromised.
“A spokeswoman for the Post-Gazette said the paper was not aware of the lawsuit and therefore could not comment on it.
“The company, based in Canonsburg, Pa., is seeking unspecified compensatory and punitive damages, asserting in the suit that the article led to ‘dramatic’ fluctuations in the company’s stock and damaged its reputation among patients and shareholders. It said in the suit that the Post-Gazette ‘manufactured a crisis where none existed.'”
Read more here.
Business Insider's Louise Ridley is joining The Female Lead, the women's empowerment charity founded by Tesco Clubcard entrepreneur Edwina…
Aruna Viswanatha has been promoted to Washington enterprise editor. She will report to Damian Paletta.…
Bowdeya Tweh has been promoted to Chicago bureau chief at the Wall Street Journal, reporting…
Fierce Healthcare has promoted Heather Landi to executive editor. She has been a senior editor.…
Business news site Quartz has hired Audrey McNamara as breaking news editor. In her role,…
Mark Stenberg of Adweek looks at how publishers such as Bloomberg and Axios are generating…